Skip to main content

Research Repository

Advanced Search

Anti-fibrotic effects of curcumin and some of its analogues in the heart

Gorabi, Armita Mahdavi; Hajighasemi, Saeideh; Kiaie, Nasim; Rosano, Giuseppe M. C.; Sathyapalan, Thozhukat; Al-Rasadi, Khalid; Sahebkar, Amirhossein

Authors

Armita Mahdavi Gorabi

Saeideh Hajighasemi

Nasim Kiaie

Giuseppe M. C. Rosano

Thozhukat Sathyapalan

Khalid Al-Rasadi

Amirhossein Sahebkar



Abstract

Cardiac fibrosis stems from the changes in the expression of fibrotic genes in cardiac fibroblasts (CFs) in response to the tissue damage induced by various cardiovascular diseases (CVDs) leading to their transformation into active myofibroblasts, which produce high amounts of extracellular matrix (ECM) proteins leading, in turn, to excessive deposition of ECM in cardiac tissue. The excessive accumulation of ECM elements causes heart stiffness, tissue scarring, electrical conduction disruption and finally cardiac dysfunction and heart failure. Curcumin (Cur; also known as diferuloylmethane) is a polyphenol compound extracted from rhizomes of Curcuma longa with an influence on an extensive spectrum of biological phenomena including cell proliferation, differentiation, inflammation, pathogenesis, chemoprevention, apoptosis, angiogenesis and cardiac pathological changes. Cumulative evidence has suggested a beneficial role for Cur in improving disrupted cardiac function developed by cardiac fibrosis by establishing a balance between degradation and synthesis of ECM components. There are various molecular mechanisms contributing to the development of cardiac fibrosis. We presented a review of Cur effects on cardiac fibrosis and the discovered underlying mechanisms by them Cur interact to establish its cardio-protective effects.

Citation

Rosano, G. M., Gorabi, A. M., Hajighasemi, S., Kiaie, N., Rosano, G. M. C., Sathyapalan, T., …Sahebkar, A. (2020). Anti-fibrotic effects of curcumin and some of its analogues in the heart. Heart Failure Reviews, 25(5), 731-743. https://doi.org/10.1007/s10741-019-09854-6

Journal Article Type Article
Acceptance Date Sep 2, 2019
Online Publication Date Sep 11, 2019
Publication Date 2020-09
Deposit Date Sep 13, 2019
Publicly Available Date Sep 12, 2020
Journal Heart Failure Reviews
Print ISSN 1382-4147
Electronic ISSN 1573-7322
Publisher Springer Verlag
Peer Reviewed Peer Reviewed
Volume 25
Issue 5
Pages 731-743
DOI https://doi.org/10.1007/s10741-019-09854-6
Keywords Curcumin; Diferuloylmethane; C66; J19; Cardiac fibrosis
Public URL https://hull-repository.worktribe.com/output/2665684
Publisher URL https://link.springer.com/article/10.1007%2Fs10741-019-09854-6

Files




You might also like



Downloadable Citations